1888PressRelease.com
1888 PressRelease Home Sign In Register About Us Sitemap
08
Feb
2009

New Treatment Discovered for Osgood-Schlatters Disease

New treatment for Osgood-Schlatters Disease shows that most if not all athletes don't have to sit out of their sport for months at a time. This new treatment can have them back playing their sport in as fast as a week.


Philadelphia, PA-NJ (1888PressRelease) February 08, 2009 - When Sports Injury expert Dr. Malcolm Conway of the Conway Clinic began treating young athletes suffering from knee pain as a result of Osgood-Schlatters Disease (OSD) he began to theorize that the current treatment was flawed. He began to research the condition and found that the of current medical treatment of OSD to take the athlete out for months at a time was dead wrong.

Dr. Conway began to treat patients with Osgood Schlatters Disease (OSD), a condition that affects the knee in many young athletes. OSD is an over use condition that causes pain, tenderness and inflammation of the knee right below the knee cap (patella). The pain usually comes on with children between the ages of 10 and 17 after some type of motion such as jumping, running and going up and down steps.

Just below the knee cap there is an area on the tibia (upper shin) known as the tibia tuberosity. This serves as an attachment point for the patellar ligament. With repetitive movement such as running, dancing, gymnastics and jumping this area begins to get ‘tugged’ on causing swelling and pain.

Current treatment by the medical establishment is a bit out dated. Presently, the most popular treatment is rest…up to 6 months...sometimes up to a year. "As you can well understand that if your son or daughter is competing in some serious athletic events this can be devastating to the young athlete", noted Dr. Conway.

“I have co-developed a treatment that we’ve found through clinical studies to be 95% faster in the healing response when compared to current medical treatment,” noted Dr. Conway.

Dr. Conway reports that he has been able to return athletes to the practice or playing field in just a few treatments. “At present, some doctors are advising their patients to take up to 6 months or more off to let this condition rest and I feel that there is no need for that,” offered Conway.

This new breakthrough treatment is called the MyoFascial Disruption Treatment (MFDT). A manual treatment that is founded on the principal that disrupted fascia is the culprit of pain.

“When the fascia becomes disrupted it causes the area to become restricted in movement which then causes other physiological breakdown. Swelling, pain and loss of strength are just a few things that will be caused from this fascial breakdown. By mechanically re-structuring the fascia back to normal you will see immediate pain relief, as well as increase range of motion and reduce swelling,” said Dr. Conway who noted that there is no age requirement for this procedure.

Completely non invasive MFDT is effective in much other type of soft tissue injuries. Shoulder and rotator cuff pain, knee pain and neck and upper back pain are just a few maladies that Dr. Conway professes good results. “Everything is completely done on an ‘out-patient’ basis in the office. There are no shot’s given, no medication and the patient should see dramatic results within the very first treatment, added Dr. Conway.

This cutting edge treatment is key for many athletes’ futures in the sports world. To be able to reduce the incident of injury and disability the patients that see Dr. Conway breathe a sigh of relief when they know they have such a pioneer to be there when they need him.

###
 

Other Related Press Releases

Eagle Publishing Releases "Making Money in the Debt Business" Wealth Building Set by Eagle Publishing, Llc

New Treatment Discovered for Osgood-Schlatters Disease by Conway Clinic

AccesStream Moves One Step Closer to a Version 1 General Availability Release by Accesstream, Lance Edelman

Contact Information

Dr. Malcolm Conway

Conway Clinic

1150 Wyoming Ave

Suite 500

18644

Voice: 570-287-7070

Visit our Site

Press Release Tools